tirzepatide pregnancy risk GLP-1 receptor agonist exposure with discontinuation before or during early #pregnancy was associated with greater gestational weight gain and increased of preterm delivery, gestational #diabetes, and hypertensive disorders. https://ja.ma/3XPqgQT Tirzepatide and Pregnancy: Safety, Risks,

More than half of the participants receiving tirzepatide lost 25% or more of their body weight during the trial period

For many of our members, this treatment has been life-changing, and we understand how worrying it can feel when change is put in front of you

Mounjaro was developed for type 2 diabetes but also supports weight loss, while Zepbound is FDA-approved specifically for long-term weight management with optimized dosing for fat loss

Vital Living Healthcare will work with you to determine the best treatment plan for sustainable results

Fibroblasts are cells that produce connective tissue components and other molecules